Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:04 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 1.30 | 1.26 | 2.80 |
| EPS, GAAP | 0.66 | 1.02 | 1.02 |
| Consensus Estimate | 0.71 | 0.69 | 3.47 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 4.48 | 3.23 | 38.82 |
| EPS, GAAP | 3.75 | 3.02 | 24.17 |
| Consensus Estimate | 2.41 | 2.23 | 8.08 |
| ABT | Industry Average | |
| P/E (TTM) | 9.63 | NA |
| P/E (Forward) | 18.14 | NA |
| PEG Ratio | 1.41 | 2.19 |
| Price/Sales | 1.45 | 18.50 |
| Beta | 0.48 | 0.70 |
| 4:49 PM | 4/4/2013 | UPDATE: U.S. Appeals Court Reverses $593 Million Award Against J&J |
| 4:44 PM | 4/4/2013 | Appeals Court Reverses $593 Million Award Against J&J |
| 4/4/2013 | Court Reverses Award Against J&J (WSJ.com) |
| 3/22/2013 | Low-Quality Stocks Have Zoomed. Time to Shift Gears? (WSJ.com) |
| 3/21/2013 | The Morning Ledger: 'Pay for Performance' Taking Root (WSJ.com) |
| 3/20/2013 | Longstanding Pay Practices Under Attack (WSJ.com) |
| 3/20/2013 | FDA Panel Votes 5-3 on Abbott Device (WSJ.com) |
| 3/18/2013 | Setback for Abbott's Mitraclip Heart Device (WSJ.com) |
| 3/18/2013 | AbbVie CEO's Compensation Up More Than 40% (WSJ.com) |
| 3/18/2013 | The Daily Startup: Japanese Firm CyberAgent to Debut Yuan Fund for China Deals (WSJ.com) |
